Elsevier

Mathematical Biosciences

Volume 123, Issue 1, September 1994, Pages 59-75
Mathematical Biosciences

Pharmacokinetic model of intravitreal drug injection

https://doi.org/10.1016/0025-5564(94)90018-3Get rights and content

Abstract

A dynamic mathematical model is developed to describe the distribution and elimination behavior of a drug in the vitreous body following intravitreal injection. The effects of three elimination pathways—the annular gap between the lens and the ciliary body (the posterior chamber), the lens, and the retina–choroid–sclera membrane—upon the concentration distribution in the vitreous body and the time course of the rate of elimination have been quantitatively demonstrated. The effects of metabolism in the vitreous body and the site of injection are also simulated. The annular gap between the lens and the ciliary body (the posterior chamber) is found to be a main route of elimination for large molecules injected into the vitreous body. For small or highly lipophilic molecules, however, both the posterior chamber and the retina–choroid–sclera membrane act as major routes of elimination. The lens pathway may contribute negligibly to the escape of drugs from the vitreous body. The concentration on the surface of the retina is appreciably affected by the site of injection or the initial distribution profiles, while the concentration gradient on the lens surface remains almost independent of the site of injection. To maintain the therapeutic concentration in the vitreous body or in the retina for a prolonged period of time, the drug must be injected into the posterior area of the vitreous body. When the drug is injected into the anterior segment of the vitreous body, the drug molecules quickly escape into the posterior chamber from the annular gap between the lens and the ciliary body. The present mathematical model describes well in vivo elimination profile of lomefloxacin following intravitreal injection.

References (12)

  • E.A. Balazs et al.

    The vitreous

  • K. Tojo et al.

    Membrane moderated controlled release

    Math. Biosci.

    (1981)
  • T.J. Franz et al.

    Transdermal delivery

  • H. Hayashi

    Pharmacological treatment of vitreoretinal diseases

    J. Eye

    (1992)
  • D.M. Maurice et al.

    Ocular pharmacokinetics

  • Y. Morita et al.

    Distribution and elimination of dexamethasone sodium m-sulfobenzoate after intravitreal injection

    J. Eye

    (1991)
There are more references available in the full text version of this article.

Cited by (33)

  • Ocular pharmacokinetics

    2022, Handbook of Basic and Clinical Ocular Pharmacology and Therapeutics
  • Virtual pharmacokinetic model of human eye

    2014, Mathematical Biosciences
    Citation Excerpt :

    In the models of Tojo et al. [8,9] the eye was modeled as a cylinder and the partial differential equations were solved with the method of lines. Wyatt modeled drug transport from the anterior chamber [10], using a self-made finite element algorithm. Transscleral drug delivery has been considered by Balachandran and Barocas [11] and Narasimhan and Vishnampet [12].

  • Computational modeling of drug distribution in the posterior segment of the eye: Effects of device variables and positions

    2014, Mathematical Biosciences
    Citation Excerpt :

    Also, several factors in intravitreal injection or ocular implantation affect local drug concentrations, that these effects should be determined properly to achieve precise drug level at target tissues. So far, several computational models have been developed to simulate drug distribution in the vitreous humor [10–21]. Some studies developed a transport model following intravitreal injection from a point source [10–15,17,18,20] while the others simulated drug administration by an intraocular or periocular implant [15,16,19].

  • Intravitreal kinetics of hesperidin, hesperetin, and hesperidin G: Effect of dose and physicochemical properties

    2012, Journal of Pharmaceutical Sciences
    Citation Excerpt :

    Vitreal pharmacokinetic parameters of hesperidin, hesperetin, and hesperidin G are presented in Tables 1, 2, and 3, respectively. Following intravitreal administration of a compound, it will be distributed within the vitreous humor and into the surrounding ocular tissues (retina, choroid, lens, and aqueous humor), from where elimination may take place.14 Distribution of an intravitreally administered drug is governed by (1) the gel structure of the vitreous humor and (2) the time taken by the compound to set up equilibrium with the peripheral ocular tissues.

View all citing articles on Scopus
View full text